Oligomerization of protein arginine methyltransferase 1 and its effect on methyltransferase activity and substrate specificity
Protein Science · 2024
DOI: 10.1002/pro.5118 ↗At a glance
Journal article in Protein Science, 2024. Written by Vincent Rossi and 8 co-authors. Institution: Department of Chemistry and Biochemistry, Utah State University, Logan, Utah, USA. Major MEDLINE topics: Protein-Arginine N-Methyltransferases, Protein Multimerization. Cited 6 times so far (Crossref); 94 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Science Foundation.
Abstract (original language)
Proper protein arginine methylation by protein arginine methyltransferase 1 (PRMT1) is critical for maintaining cellular health, while dysregulation is often associated with disease. How the activity of PRMT1 is regulated is therefore paramount, but is not clearly understood. Several studies have observed higher order oligomeric species of PRMT1, but it is unclear if these exist at physiological concentrations and there is confusion in the literature about how oligomerization affects activity. We therefore sought to determine which oligomeric species of PRMT1 are physiologically relevant, and quantitatively correlate activity with specific oligomer forms. Through quantitative western blotting, we determined that concentrations of PRMT1 available in a variety of human cell lines are in the sub‐micromolar to low micromolar range. Isothermal spectral shift binding data were modeled to a monomer/dimer/tetramer equilibrium with an EC 50 for tetramer dissociation of ~20 nM. A combination of sedimentation velocity and Native polyacrylamide gel electrophoresis experiments directly confirmed that the major oligomeric species of PRMT1 at physiological concentrations would be dimers and tetramers. Surprisingly, the methyltransferase activity of a dimeric PRMT1 variant is similar to wild type, tetrameric PRMT1 with some purified substrates, but dimer and tetramer forms of PRMT1 show differences in catalytic efficiencies and substrate specificity for other substrates. Our results define an oligomerization paradigm for PRMT1, show that the biophysical characteristics of PRMT1 are poised to support a monomer/dimer/tetramer equilibrium in vivo, and suggest that the oligomeric state of PRMT1 could be used to regulate substrate specificity.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Chemistry and Biochemistry, Utah State University, Logan, Utah, USA.
- NanoTemper Technologies, South San Francisco, California, USA.
ORCID profiles: Vincent Rossi, Sarah E Nielson, Isabella Lonardo, Emeline Haroldsen, Owen M Price, Joan M Hevel
Funding
- National Science Foundation
Cite
APA
Rossi, V., Nielson, S. E., Ortolano, A., Lonardo, I., Haroldsen, E., Comer, D., Price, O. M., Wallace, N., & Hevel, J. M. (2024). Oligomerization of protein arginine methyltransferase 1 and its effect on methyltransferase activity and substrate specificity. Protein Science. https://doi.org/10.1002/pro.5118
Vancouver
Rossi V, Nielson SE, Ortolano A, Lonardo I, Haroldsen E, Comer D, et al. Oligomerization of protein arginine methyltransferase 1 and its effect on methyltransferase activity and substrate specificity. Protein Science. 2024. doi:10.1002/pro.5118
BibTeX
@article{Rossi2024,
author = {Rossi, Vincent and Nielson, Sarah E and Ortolano, Ariana and Lonardo, Isabella and Haroldsen, Emeline and Comer, Drake and Price, Owen M and Wallace, Nathan and Hevel, Joan M},
title = {Oligomerization of protein arginine methyltransferase 1 and its effect on methyltransferase activity and substrate specificity},
journal = {Protein Science},
year = {2024},
doi = {10.1002/pro.5118}
}
EUVIMED